Tags |
|
|
Links |
|
|
Advice Pool - Management: Leadership And The Use Of Fear As A Motivator
There are many organizations that still subscribe to the belief that fear is the best motivator for i
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ts employees and that it creates a more robust and competitive entity in the market place.
As an exe
As an exe
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
cutive coach and psychiatrist for over 20 years I wish to dispel this destructive myth once and for a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ll here.
What is the true benefit to an organization of using fear as a motivator?
Well let me coun
What is the true benefit to an organization of using fear as a motivator?
Well let me coun
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
the ways:
1. It creates increased emotional & physical stress for employees.
2. This leads to acce
1. It creates increased emotional & physical stress for employees.
2. This leads to acce
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
lerated turnover and burnout of high caliber individuals.
3. This leads to a major reduction in crea
3. This leads to a major reduction in crea
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
tivity and overall performance.
4. It leads to employee dissatisfaction and greater resistance to ma
4. It leads to employee dissatisfaction and greater resistance to ma
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
agement directives from above.
5. This leads to greater management-employee conflict.
6. This sipho
5. This leads to greater management-employee conflict.
6. This sipho
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ns off creative energy meant to produce revenues into wasteful intra-organizational conflicts that ma
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ke the organization weak, ineffective, vulnerable and less able to survive.
7. Oh yes, last but not
7. Oh yes, last but not
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
east, it leads to an escalation in operating costs through , poor performance, sick leave, health & i
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
nsurance plans payments, retraining, and other inefficiencies.
So with all these benefits why would
So with all these benefits why would
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
any manager not want to employ fear as a motivator?
Well in fact it is usually the manager's “fear”
Well in fact it is usually the manager's “fear”
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
that is motivating such a choice in the first place. So you see there are serious risks that can lite
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ally bring an organization to its knees with such a strategy.
There is a better way!
It entails eac
There is a better way!
It entails eac
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
h individual working from a place of passion, purpose, creativity, energy, joy, desire, freedom, heal
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
th, enthusiasm and so on.
Unfortunately most organizations are still too afraid to allow such a posi
Unfortunately most organizations are still too afraid to allow such a posi
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ive and resilient atmosphere from living within their walls.
The fear is, there's that word again, t
The fear is, there's that word again, t
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
hat nothing would get done, correct?
Well have it your way then.
If you do see the logic in this ar
Well have it your way then.
If you do see the logic in this ar
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
gument and would like to build a truly resilient organization kindly contact me at the web link below
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/23277/advicepool-Management-Leadership-And-The-Use-Of-Fear-As-A-Motivator.html">Management: Leadership And The Use Of Fear As A Motivator</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/23277/advicepool-Management-Leadership-And-The-Use-Of-Fear-As-A-Motivator.html]Management: Leadership And The Use Of Fear As A Motivator[/url]
Related Articles:
Improve Your People Skills With A Temporary Secretarial Job
Business For Sale - How to Tell if the Profits are Real
Bookmark it:
|